Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Exoma Energy Extends CNOOC Partnership

Published 09/30/2012, 05:09 AM
Updated 07/09/2023, 06:31 AM
CNOOC ups its interests

Exoma Energy (EXE.AX) has announced a substantial extension of its partnership with global major CNOOC. In addition to extending its existing farm-in agreement, CNOOC will take a 13% equity stake in Exoma, extendable to 19.9%. The deal provides Exoma with A$10.7m of direct new funding and $12.7m of further work programme funding. The extension of CNOOC's commitment signals continuing confidence in the plausibility and materiality of Exoma's Galilee and Eromanga Basin acreage.
Exoma Energy
Two-tiered CNOOC commitment highly symbolic
In addition to extending its existing farm-in and funding carry of Exoma, CNOOC and Exoma have agreed for CNOOC to take a cornerstone equity stake in Exoma. As well as the parameters of the deal providing two fresh sets of benchmark metrics, consummation represents further endorsement of a relationship that continues to strengthen and is clearly in very good corporate health.

Work programme reigned-in
As operator of the JV’s permits, Exoma has also announced the JV’s decision to significantly reduce its 2012 work programme while it analyses results from the drilling programme to date and considers its forward strategy. With generally disappointing results from its CSG targets, we expect the JV to refocus towards conventional oil and appraising the Toolebuc shale which is known to stretch across 39,000km2 (9.6 million acres) of the JVs granted and contingent permit areas.

Options and overhang nearly gone
Exoma has a substantial parcel of 180m A10cps share options on issue, which expire on 30 September. With potentially A$18m of new funding at stake, the options were shaping as a defining event in determining Exoma’s forward funding profile. Although Exoma would undoubtedly welcome any buffer that option conversions would still provide, with CNOOC having extended its funding support, potential option monies are now much less material to Exoma’s funding outlook.

Valuation thesis unchanged
Our valuation thesis remains unchanged from our initiation report published on 6 August. The news since of an unsuccessful result from the potentially defining Katherine West well has nullified what would otherwise have served as a firm NAV catalyst. Based on the deal metrics that fall from the new CNOOC arrangements, we infer a midpoint valuation of A$0.15 per share.

To Read the Entire Report Please Click on the pdf File Below.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.